Biomednewsbreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Advances Non-Opioid Fibromyalgia Drug Toward FDA Decision
Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining attention as it advances TNX-102 SL, a non-opioid investigational therapy for fibromyalgia, toward po ...
Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year
CHATHAM, NJ / ACCESS Newswire / March 31, 2025 /This post was written and published as a collaboration between the in-house ...
Yahoo Finance21h
Kohl’s Will Be Closing Stores in 15 States by April: Is Yours One of Them?
As brick-and-mortar retailers continue to struggle, Kohl’s announced that it will be closing 27 stores in underperforming locations by April 2025. “We always take these decisions very ...
pharmaphorum21h
The race for obesity drug assets heats up
A different approach is that of Tonix Pharmaceutical, which is exploring the delivery of intranasal oxytocin for weight loss. The company began enrolment of a phase 2 study in July 2023 ...